679 results on '"Hviid, Anders"'
Search Results
2. Optimizing Signal Management in a Vaccine Adverse Event Reporting System: A Proof-of-Concept with COVID-19 Vaccines Using Signs, Symptoms, and Natural Language Processing
3. Comparative effectiveness of bivalent BA.4–5 or BA.1 mRNA booster vaccines among immunocompromised individuals across three Nordic countries: A nationwide cohort study
4. Use of DPP4 Inhibitors and GLP-1 Receptor Agonists and Risk of Intestinal Obstruction: Scandinavian Cohort Study
5. Machine learning identifies risk factors associated with long-term sick leave following COVID-19 in Danish population
6. A Danish questionnaire study of acute symptoms of SARS-CoV-2 infection by variant, vaccination status, sex and age
7. A hybrid register and questionnaire study of Covid-19 and post-acute sick leave in Denmark
8. Author Correction: Vitamin D status and severity of COVID-19
9. Comparative effectiveness of the monovalent XBB.1.5-containing covid-19 mRNA vaccine across three Nordic countries
10. Preterm birth, stillbirth and early neonatal mortality during the Danish COVID-19 lockdown
11. A nationwide questionnaire study of post-acute symptoms and health problems after SARS-CoV-2 infection in Denmark
12. Understanding thrombosis with thrombocytopenia syndrome after COVID-19 vaccination
13. Vitamin D status and severity of COVID-19
14. Postacute symptoms 4 months after SARS-CoV-2 infection during the Omicron period: a nationwide Danish questionnaire study.
15. SARS-CoV-2 Infection and Risk of Postacute Psychiatric and Neurologic Diagnoses
16. Booster vaccination with SARS-CoV-2 mRNA vaccines and myocarditis in adolescents and young adults: a Nordic cohort study
17. COVID-19 Vaccine Effectiveness Among Adolescents
18. Association between quadrivalent human papillomavirus vaccination and selected syndromes with autonomic dysfunction in Danish females : population based, self-controlled, case series analysis
19. Comparative cardiovascular and renal effectiveness of empagliflozin and dapagliflozin: Scandinavian cohort study
20. Association of glucagon-like peptide-1 receptor agonists with serious liver events among patients with type 2 diabetes: A Scandinavian cohort study.
21. Glucagon-like peptide 1 receptor agonist use and risk of thyroid cancer: Scandinavian cohort study.
22. Association between atopic disease and vaccination granulomas: A nested case–control study.
23. Association of glucagon-like peptide-1 receptor agonists with serious liver events among patients with type 2 diabetes: A scandinavian cohort study
24. Association between atopic disease and vaccination granulomas: A nested case–control study
25. Optimizing Signal Management in a Vaccine Adverse Event Reporting System: A Proof-of-Concept with COVID-19 Vaccines Using Signs, Symptoms, and Natural Language Processing
26. Concomitant use of statins and macrolide antibiotics and risk of serious renal events: A nationwide cohort study
27. SARS-CoV-2 Infection and Postacute Risk of Non–Coronavirus Disease 2019 Infectious Disease Hospitalizations: A Nationwide Cohort Study of Danish Adults Aged ≥50 Years.
28. A register and questionnaire study of long-term general health symptoms following SARS-CoV-2 vaccination in Denmark.
29. Cumulative Incidence of Thiazide-Induced Hyponatremia: A Population-Based Cohort Study.
30. Use of DPP4 Inhibitors and GLP-1 Receptor Agonists and Risk of Intestinal Obstruction: Scandinavian Cohort Study
31. The impact of the COVID-19 lockdown on birthweight among singleton term birth in Denmark
32. Risk of Type 1 Diabetes in Children is Not Increased after SARS-CoV-2 Infection: A Nationwide Prospective Study in Denmark
33. SARS-CoV-2 infection and post-acute risk of non-Covid-19 infectious disease hospitalizations: a nationwide cohort study of Danish adults aged ≥50 years
34. A hybrid register and questionnaire study of Covid-19 and post-acute sick leave in Denmark.
35. Risk of Incident Thromboembolic and Ischemic Events After COVID-19 Vaccination Compared With SARS-CoV-2 Infection
36. Clinical outcomes of myocarditis after SARS-CoV-2 mRNA vaccination in four Nordic countries: population based cohort study
37. Safety of bivalent omicron-containing mRNA-booster vaccines: a nationwide cohort study
38. Comparative effectiveness of the bivalent BA.4-5 and BA.1 mRNA-booster vaccines in the Nordic countries
39. Acute Symptoms of SARS-CoV-2 Infection by Variant, Vaccination Status, Sex and Age: A Questionnaire Study in Denmark
40. Association of Glucagon-Like Peptide-1 Receptor Agonists with Serious Liver Events: A Scandinavian Cohort Study
41. Identifying Heterogeneity in the Effect of Covid-19 on Long-Term Sick Leave Using Causal Machine Learning
42. Author Correction:Vitamin D status and severity of COVID-19 (Scientific Reports, (2022), 12, 1, (19823), 10.1038/s41598-022-21513-9)
43. Adverse Events After XBB.1.5-Containing COVID-19 mRNA Vaccines.
44. Comparative effectiveness of bivalent BA.4-5 and BA.1 mRNA booster vaccines among adults aged ≥50 years in Nordic countries: nationwide cohort study.
45. Safety of BA.4-5 or BA.1 bivalent mRNA booster vaccines: nationwide cohort study.
46. Comparative effectiveness of heterologous third dose vaccine schedules against severe covid-19 during omicron predominance in Nordic countries: population based cohort analyses.
47. Use of different types of angiotensin converting enzyme inhibitors and mortality in systolic heart failure
48. Booster Vaccination with SARS-CoV-2 mRNA Vaccines and Myocarditis Risk in Adolescents and Young Adults: A Nordic Cohort Study of 8.9 Million Residents
49. Sodium-glucose co-transporter 2 inhibitor treatment and risk of atrial fibrillation: Scandinavian cohort study
50. Sodium–Glucose Cotransporter 2 Inhibitor Treatment and Risk of Atrial Fibrillation: Scandinavian Cohort Study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.